ZiP Diagnostics
ZiP Diagnostics is an Australian biotech that designs and manufactures portable, low-cost LAMP-based molecular diagnostic instruments and single-use test cartridges for infectious diseases in human, animal, and environmental health applications.
- Company typePrivate
- Founded2019
- HeadquartersCollingwood, Australia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What ZiP Diagnostics does
ZiP Diagnostics is an Australian biotechnology company founded in 2019 and headquartered in Collingwood, Victoria, that develops and manufactures low-cost, rapid, point-of-care molecular diagnostic tests for infectious diseases. The company operates a vertically integrated manufacturing capability in-house producing recombinant proteins, molecular assay chemistry, fluidic cartridges, lyophilised reagents, and reader instrumentation, with all significant components manufactured domestically in Australia. Its core platform is the ZiP-P2, a 2.3 kg portable analyser that runs loop-mediated isothermal amplification (LAMP) of nucleic acids, delivering PCR-comparable sensitivity and specificity with sample-to-result times of 10–20 minutes. The platform uses room-temperature-stable lyophilised reagents, eliminating cold-chain requirements, and supports HL7/LIS connectivity via USB, ethernet, and serial ports for laboratory integration.
ZiP generates revenue primarily through one-time sales of the ZiP-P2 instrument and recurring sales of single-use test cartridges, with an e-commerce webstore as the principal direct sales channel supported by conference-driven enterprise lead generation at events such as ADLM, AusBiotech, ESCMID Global, POC25, and Ozwater. The product portfolio spans three verticals: human health (ZiP-CoVx-P2 SARS-CoV-2 test, TGA ARTG listed with 98.3% sensitivity and 99.0% specificity versus RT-PCR); animal health (ZiP-ASF-P2, ZiP-FMD-P2, ZiP-LSDV-P2, ZiP-BVD-P2 for livestock biosecurity); and environmental water testing (ZiP-Entero-P2 and ZiP-Bactx-P2 for faecal indicator and human-source tracking). Two additional platforms, ZiP-H4 (up to 8 gene targets per run with integrated sample preparation) and ZiP-ARRAY (lateral flow array printing), extend the technology stack for multiplexed applications. The company also offers custom assay development services and quality control kits, with regulatory coverage across Australia (TGA ARTG 457145, 478427), the European Union (CE Mark), the United Kingdom (UKCA), and ISO 13485 / IEC 61010-1 quality and safety certifications.
ZiP serves a diverse and largely early-stage customer base including government and municipal water monitoring programs in Tasmania, academic and clinical research groups (Royal Melbourne Hospital, University of Melbourne, Kamuzu University of Health Sciences in Malawi, Menzies School of Health Research), international livestock disease agencies (NARO, NADDEC, Makerere University, the Canadian Food Inspection Agency in Uganda), and defence-related partners (DMTC Limited's Health Security Systems Australia division). The company's expansion strategy combines new product launches across respiratory, STI, hepatitis, HIV, mosquito-borne, and neglected tropical disease panels with geographic extension into Sub-Saharan Africa, the Indo-Pacific, and Southeast Asia. Manufacturing capacity is being scaled roughly twenty-fold from 50,000 to 1,000,000 tests per year, supported by a recent AUD $659,278 funding round from MTPConnect in mid-2025.
ZiP Diagnostics firmographics
Firmographics- Name
- ZiP Diagnostics
- Legal name
- Zip Diagnostics Pty Ltd
- Website
- https://zipdiag.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ZiP Diagnostics is an Australian biotech that designs and manufactures portable, low-cost LAMP-based molecular diagnostic instruments and single-use test cartridges for infectious diseases in human, animal, and environmental health applications.
- Ownership category
- akta.pro rank
ZiP Diagnostics industry classification
Industry- Product category
- Point-of-Care Molecular Diagnostics
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges) (HLAHAOAI)
- akta.pro secondary industries
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices) (AFALAEAK), Wastewater & Environmental Pathogen Surveillance (HLAJABAI), Quality Management & Regulatory Compliance (CLIA/CAP/ISO) for Labs (HLACAMAH)
Keywords
Where ZiP Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Collingwood
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
ZiP Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic Instruments: Sale of ZiP-P2 portable diagnostic instruments and accessories (barcode scanners, cables)
- Single-Use Test Cartridges: Recurring revenue from sale of single-use test cartridges for the ZiP-P2 platform. Products include ZiP-CoVx-P2 (SARS-CoV-2), ZiP-ASF-P2 (African Swine Fever), ZiP-FMD-P2 (Foot-and-Mouth Disease), ZiP-LSDV-P2 (Lumpy Skin Disease), ZiP-Entero-P2 (Enterococcus), ZiP-Bactx-P2 (Bacteroides dorei)
- Quality Control Kits: Sale of positive control kits for quality assurance testing (SARS-CoV-2, Entero, Bactx)
- Assay Customisation Service: Custom assay development services for specific diagnostic needs
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | African Swine Fever Test - Box of 20 tests |
| One time/ perpetual license | Pay-as-you-go | ZiP-P2 Instrument Platform |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
ZiP Diagnostics product offering
Product offeringCore offering
ZiP Diagnostics manufactures and sells the ZiP-P2 portable molecular diagnostic instrument and a library of single-use lyophilised test cartridges for rapid point-of-care detection of infectious diseases and faecal contamination. The platform uses LAMP isothermal nucleic acid amplification to deliver PCR-comparable results in 10-20 minutes across human health, animal health, and environmental water testing applications. The company also offers assay customisation services and quality control kits, with all instruments, assays, and cartridges produced domestically at its Collingwood, Victoria facility.
Product overview
ZiP Diagnostics offers a vertically integrated point-of-care molecular diagnostics platform consisting of the ZiP-P2 instrument (a 2.3 kg portable LAMP-based analyser) and a growing library of single-use assay cartridges. The platform provides PCR-comparable sensitivity (>95%) with results in 10-20 minutes, using lyophilised reagents that require no cold chain. Core products include ZiP-CoVx-P2 (SARS-CoV-2, TGA listed), ZiP-ASF-P2 (African Swine Fever), ZiP-FMD-P2 (Foot-and-Mouth Disease), ZiP-LSDV-P2 (Lumpy Skin Disease), ZiP-Entero-P2 (Enterococcus for water testing), and ZiP-Bactx-P2 (Bacteroides dorei for faecal source tracking). Supporting platforms include ZiP-H4 (multi-target detection, up to 8 targets) and ZiP-ARRAY (lateral flow array printing). The company also manufactures control kits, barcode scanners, and training equipment. All products are Australian-made in Collingwood, Victoria, with assays, cartridges, and instruments domestically produced.
Differentiator
Problem solved
Functional benefit
Brands
- ZiP-P2: Portable molecular diagnostic instrument platform using isothermal nucleic acid amplification (LAMP) technology for point-of-care testing.
- ZiP-H4
- ZiP-ARRAY
Products and services
- ZiP-P2 Instrument A 2.3 kg portable molecular diagnostic analyser running LAMP isothermal nucleic acid amplification. Features touchscreen-guided workflow, battery capability, two random-access test bays, HL7/LIS connectivity via USB, ethernet, and serial ports. Dimensions 185 x 205 x 122 mm. Used by clinics, farms, and environmental testing programs.
- ZiP-CoVx-P2 Rapid molecular diagnostic test for SARS-CoV-2 detection running on the ZiP-P2 instrument. TGA ARTG listed (457145) with 98.3% sensitivity and 99.0% specificity vs RT-PCR, delivering results in 10-20 minutes using lyophilised reagents that require no cold chain. For clinical and point-of-care use.
- ZiP-ASF-P2 Rapid molecular diagnostic test for African Swine Fever virus detection in pigs. Accepts respiratory, blood, or tissue samples, returning results in 15-30 minutes on the ZiP-P2 platform. Sold as a box of 20 tests at AUD $700. Research Use Only status with approved institutions.
- ZiP-FMD-P2 Rapid molecular diagnostic test for Foot-and-Mouth Disease virus detection in livestock. Field-deployable on the ZiP-P2 platform for on-site testing at farms, abattoirs, and border checkpoints.
- ZiP-LSDV-P2 Rapid molecular diagnostic test for Lumpy Skin Disease Virus detection in cattle. Field-deployable on the ZiP-P2 platform for on-site screening at farms and livestock handling facilities.
- ZiP-Entero-P2 Environmental water testing assay for Enterococcus spp. detection as a faecal indicator bacteria. Enables rapid beach and recreational water quality monitoring on the ZiP-P2 platform with results in 10-20 minutes.
- ZiP-Bactx-P2 Environmental water testing assay detecting Bacteroides dorei using the human-specific HF183 16S rRNA genetic marker. Provides faecal source tracking to distinguish human sewage contamination from animal sources, running on the ZiP-P2 platform.
- ZiP-BVD-P2 Rapid molecular diagnostic test for Bovine Viral Diarrhoea Virus (BVDV) detection in cattle. Sold on the ZiP-P2 platform with Research Use Only status for validation testing by approved institutions.
- ZiP-H4 Test Platform Point-of-care test platform with integrated sample preparation in cartridge and instrument. Single cartridge system detecting up to 8 gene targets per test run, including genital swabs and urine sample types. Currently Research Use Only.
- ZiP-ARRAY Test Platform Test platform optimised for detection and interpretation of small spot sizes on lateral flow membranes or functionalised plastic surfaces. Uses assay spotter technology for printing protein or particle spots onto test strip cartridges.
- Control Kits Quality control reagent kits including ZiP-Entero Positive Control Kit, ZiP-Bactx Positive Control Kit, and SARS-CoV-2 Positive Control Kit. Sold separately for verification of test performance and batch quality assurance on the ZiP-P2 platform.
- Datalogic Quickscan QD2590 Barcode Scanner Barcode scanner accessory for the ZiP-P2 system, sold as a standalone product to enable sample and cartridge tracking.
- ZiP-DEMO-P2 Training Box Training and demonstration package for the ZiP-P2 instrument, sold as a standalone product for user training and product familiarisation.
- Assay Customisation Service Custom assay development service offered by ZiP Diagnostics to design and develop molecular diagnostic assays for specific customer diagnostic needs on the ZiP platform.
Companies that use ZiP Diagnostics
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles4 records
ZiP Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature6 records
ZiP Diagnostics partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and major.
- DMTC LimitedcoreCollaboration with DMTC's Health Security Systems Australia division involves developing a multiplexed point-of-care test for mosquito-borne diseases of priority in the Indo-Pacific region. The product has dual use for defence and health applications. DMTC's Head of Government Relations noted importance of local manufacturing for defence and national security capabilities.
- AxxincoreCollaboration with Australian manufacturer Axxin to develop an innovative point-of-care diagnostic platform for detection of mosquito-borne infections. ZiP leads development of multiplexed test capable of detecting dengue fever, chikungunya, and malaria from a single sample.
- University of MelbournecoreCollaborative team from University of Melbourne and Kamuzu University of Health Sciences in Malawi, supported by MDHS Innovation Fund, field-tested ZiP's portable diagnostic device for detecting active syphilis infections in pregnant women. Device received regulatory approval in Australia and returns results within 15-20 minutes.
- Kamuzu University of Health Sciences (Malawi)corePartnership with Kamuzu University of Health Sciences in Malawi for field trial of syphilis diagnostic device. The project team plans formal trial evaluating the device against current best-practice diagnostic methods and is exploring further funding to scale the innovation across Malawi.
- National Agriculture Research Organisation (NARO) UgandamajorField validation of ZiP-P2 rapid molecular tests for four high-impact livestock diseases in Uganda. Working alongside Uganda's NARO and NADDEC to evaluate the platform in real-world settings for faster, high-quality molecular detection at point of need.
- National Animal Disease Diagnostics and Epidemiology Centre (NADDEC) UgandamajorPartnership with NADDEC for field validation of ZiP-P2 platform in Uganda, evaluating rapid molecular tests for Foot-and-Mouth Disease, Lumpy Skin Disease Virus, African Swine Fever, and BVDV.
- Makerere UniversitymajorCollaboration with Makerere University in Uganda for field validation work on livestock disease diagnostics.
- Canadian Food Inspection Agency (CFIA)majorCollaboration with CFIA in support of ZiP-P2 platform validation for livestock disease detection in Uganda, bringing together international expertise for robust testing solutions.
- Royal Melbourne Hospital (Victorian Infectious Diseases Service)coreTEDI (Test Evaluation, Development and Implementation) study - obtaining fresh specimens from volunteers for early-stage analytical validation of novel diagnostic tests. Lead investigator Assoc/Prof Joe Sasadeusz, co-investigator Dr Jack Richards (ZiP).
- Derwent Estuary ProgrammajorPartnership with Derwent Estuary Program to deploy ZiP-Bactx-P2 rapid molecular diagnostic assay for human-specific faecal source tracking. Assessment covered six Tasmanian councils, managed with Department of Health and EPA Tasmania.
- Menzies School of Health ResearchcoreWorking with Menzies School of Health Research to trial the scabies and co-infections diagnostic test. Collaborative team working on significant impact in controlling scabies, a skin parasite affecting more than 200 million people each year.
Scale indicators6 records
Recent moves6 records
Expansion highlights9 records
ZiP Diagnostics competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Customer concentration
ZiP Diagnostics social profiles
Digital presenceZiP Diagnostics compliance and trust
Trust signalCompliance5 records
ZiP Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
ZiP Diagnostics leadership team
Management profileNumber of profiles
Profiles3 records
ZiP Diagnostics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ZiP Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ZiP Diagnostics
What does ZiP Diagnostics do?
ZiP Diagnostics manufactures and sells the ZiP-P2 portable molecular diagnostic instrument and a library of single-use lyophilised test cartridges for rapid point-of-care detection of infectious diseases and faecal contamination. The platform uses LAMP isothermal nucleic acid amplification to deliver PCR-comparable results in 10-20 minutes across human health, animal health, and environmental water testing applications. The company also offers assay customisation services and quality control kits, with all instruments, assays, and cartridges produced domestically at its Collingwood, Victoria facility.
Is ZiP Diagnostics a public or private company?
ZiP Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ZiP Diagnostics founded?
ZiP Diagnostics was founded in 2019. It employs 11 to 50 people.
Where is ZiP Diagnostics based?
ZiP Diagnostics is headquartered in Collingwood, Australia, in the Oceania region.
How does ZiP Diagnostics make money?
Four revenue lines are on record. Diagnostic Instruments are the primary driver. The others are single-Use Test Cartridges, quality Control Kits and assay Customisation Service.
Does ZiP Diagnostics have an API?
No public API is recorded for ZiP Diagnostics.
What industry is ZiP Diagnostics in?
ZiP Diagnostics's product category is Point-of-Care Molecular Diagnostics. Its primary akta.pro industry code is HLAHAOAI, Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges), with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 334516 and its SIC code is 3826.